Semaglutide 6-months therapy of type 2 diabetes mellitus restores adipose progenitors potential to develop metabolically active adipocytes

CONCLUSIONS: Our study has revealed that semaglutide 6-month therapy has not only systemic anorexigenic effects, but can markedly improve adipose tissue health. We have demonstrated critical restoration of ADSC renewal functions, which potentially can be involved in semaglutide based weight loss.PMID:38493915 | DOI:10.1016/j.ejphar.2024.176476

Source: European Journal of Pharmacology - March 17, 2024 Category: Drugs & Pharmacology Authors: I Stafeev M Agareva S Michurina A Tomilova E Shestakova E Zubkova M Sineokaya E Ratner M Menshikov Ye Parfyonova M Shestakova Source Type: research